Plain Language Summaries is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • How to
  • FAQs
  • Publications
  • Advisory Panel
    • Plain Language Advisors
    • Scientific Content Advisors
  • Supporters
  • Blog
  • About us
  • Contact Us

PD-1

25th Feb 2026

TASUKI-52 study of combination therapy using nivolumab, platinum chemotherapy, and bevacizumab for advanced or recurrent nonsquamous NSCLC: a plain language summary

Copyright © 2026 · Plain Language Summaries · Terms and conditions · Privacy policy · Cookie policy